4//SEC Filing
Garrison Michael David 4
Accession 0001062993-25-013065
CIK 0000010795other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 5:29 PM ET
Size
11.0 KB
Accession
0001062993-25-013065
Insider Transaction Report
Form 4
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
- Exercise/Conversion
Common Stock
2025-07-18$147.68/sh+6,360$939,245→ 11,247 total - Sale
Common Stock
2025-07-18$180.29/sh−1,184$213,463→ 4,888 total - Sale
Common Stock
2025-07-18$181.50/sh−1$182→ 4,887 total - Disposition to Issuer
Common Stock
2025-07-18$180.29/sh−5,175$933,001→ 6,072 total - Exercise/Conversion
Stock Appreciation Rights
2025-07-18−6,360→ 0 totalExercise: $147.68From: 2016-11-26Exp: 2025-11-26→ Common Stock (6,360 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vested in four annual installments beginning one year after grant.
Issuer
BECTON DICKINSON & CO
CIK 0000010795
Entity typeother
Related Parties
1- filerCIK 0001944816
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 5:29 PM ET
- Size
- 11.0 KB